Clenbuterol, a Selective β2-Adrenergic Receptor Agonist, Inhibits or Limits Post-Stroke Pneumonia, but Increases Infarct Volume in MCAO Mice

References

• Prass K, Braun JS, Dirnagl U, et al. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke. 2006;37(10):2607–2612. doi:10.1161/01.STR.0000240409.68739.2b
   PubMed Web of Science ®Google Scholar
• Gelderblom M, Leypoldt F, Steinbach K, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke. 2009;40(5):1849–1857. doi:10.1161/STROKEAHA.108.534503
   PubMed Web of Science ®Google Scholar
• Martín-Cordero L, García JJ, Hinchado MD, et al. Influence of exercise on NA- and Hsp72-induced release of IFN γ by the peritoneal suspension of macrophages and lymphocytes from genetically obese Zucker rats. J Physiol Biochem. 2013;69(1):125–131. doi:10.1007/s13105-012-0196-5
   PubMed Web of Science ®Google Scholar
• Bosmann M, Grailer JJ, Zhu K, et al. Anti-inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury. FASEB J. 2012;26(5):2137–2144. doi:10.1096/fj.11-201640
   PubMed Web of Science ®Google Scholar
• Hervé J, Haurogné K, Bacou E, et al. β2-adrenergic stimulation of dendritic cells favors IL-10 secretion by CD4+ T cells. Immunol Res. 2017;65(6):1156–1163. doi:10.1007/s12026-017-8966-3
   PubMed Web of Science ®Google Scholar
• Ağaç D, Estrada LD, Maples R, et al. The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion. Brain Behav Immun. 2018;74:176–185. doi:10.1016/j.bbi.2018.09.004
   PubMed Web of Science ®Google Scholar
• Culmsee C, Semkova I, Krieglstein J. NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem Int. 1999;35(1):47–57. doi:10.1016/S0197-0186(99)00032-7
   PubMed Web of Science ®Google Scholar
• Culmsee C, Stumm RK, Schäfer MK, et al. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol. 1999;379(1):33–45. doi:10.1016/S0014-2999(99)00452-5
   PubMed Web of Science ®Google Scholar
• Lechtenberg KJ, Meyer ST, Doyle JB, et al. Augmented β2-adrenergic signaling dampens the neuroinflammatory response following ischemic stroke and increases stroke size. J Neuroinflammation. 2019;16(1):112. doi:10.1186/s12974-019-1506-4
   PubMed Web of Science ®Google Scholar
• Han RQ, Ouyang YB, Xu L, et al. Postischemic brain injury is attenuated in mice lacking the beta2-adrenergic receptor. Anesth Analg. 2009;108(1):280–287. doi:10.1213/ane.0b013e318187ba6b
   PubMed Web of Science ®Google Scholar
• White RE, Palm C, Xu L, et al. Mice lacking the β2 adrenergic receptor have a unique genetic profile before and after focal brain ischaemia. ASN Neuro. 2012;4:343–356. doi:10.1042/AN20110020
   Web of Science ®Google Scholar
• Winklewski PJ, Radkowski M, Demkow U. Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke. J Neuroinflammation. 2014;11:213. doi:10.1186/s12974-014-0213-4
   PubMed Web of Science ®Google Scholar
• Katzan IL, Cebul RD, Husak SH, et al. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620–625. doi:10.1212/01.WNL.0000046586.38284.60
   PubMed Web of Science ®Google Scholar
• Liu T, Yang L, Han X, et al. Local sympathetic innervations modulate the lung innate immune responses. Sci Adv. 2020;6(20):eaay1497. doi:10.1126/sciadv.aay1497
   PubMed Web of Science ®Google Scholar
• Prass K, Meisel C, Höflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198(5):725–736. doi:10.1084/jem.20021098
   PubMed Web of Science ®Google Scholar
• Wong CHY, Jenne CN, Lee WY, et al. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science. 2011;334(6052):101–105. doi:10.1126/science.1210301
   PubMed Web of Science ®Google Scholar
• Cardoso-Sousa L, Aguiar EMG, Caixeta DC, et al. Effects of salbutamol and phlorizin on acute pulmonary inflammation and disease severity in experimental sepsis. PLoS One. 2019;14(9):e0222575. doi:10.1371/journal.pone.0222575
   PubMed Web of Science ®Google Scholar
• Chiang T, Messing RO, Chou WH. Mouse model of middle cerebral artery occlusion. J Vis Exp. 2011;(48):2761. doi:10.3791/2761
   PubMed Web of Science ®Google Scholar
• Liang X, Hu Q, Li B, et al. Follistatin-like 1 attenuates apoptosis via disco-interacting protein 2 homolog A/Akt pathway after middle cerebral artery occlusion in rats. Stroke. 2014;45(10):3048–3054. doi:10.1161/STROKEAHA.114.006092
   PubMed Web of Science ®Google Scholar
• Bieber M, Werner RA, Tanai E, et al. Stroke-induced chronic systolic dysfunction driven by sympathetic overactivity. Ann Neurol. 2017;82(5):729–743. doi:10.1002/ana.25073
   PubMed Web of Science ®Google Scholar
• Gendron A, Teitelbaum J, Cossette C, et al. Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res. 2002;955(1–2):85–97. doi:10.1016/S0006-8993(02)03368-1
   PubMed Web of Science ®Google Scholar
• Myers MG, Norris JW, Hachniski VC, et al. Plasma norepinephrine in stroke. Stroke. 1981;12(2):200–204. doi:10.1161/01.STR.12.2.200
   PubMed Web of Science ®Google Scholar
• D’Alessio FR, Tsushima K, Aggarwal NR, et al. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest. 2009;119(10):2898–2913. doi:10.1172/JCI36498
   PubMed Web of Science ®Google Scholar
• Sander D, Winbeck K, Klingelhöfer J, et al. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology. 2001;57(5):833–838. doi:10.1212/WNL.57.5.833
   PubMed Web of Science ®Google Scholar
• Bergquist J, Tarkowski A, Ewing A, et al. Catecholaminergic suppression of immunocompetent cells. Immunol Today. 1998;19(12):562–567. doi:10.1016/S0167-5699(98)01367-X
   PubMedGoogle Scholar
• Felten SY, Olschowka J. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic like contacts on lymphocytes in the splenic white pulp. J Neurosci Res. 1987;18(1):37–48. doi:10.1002/jnr.490180108
   PubMed Web of Science ®Google Scholar
• Hug A, Dalpke A, Wieczorek N, et al. Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke. 2009;40(10):3226–3232. doi:10.1161/STROKEAHA.109.557967
   PubMed Web of Science ®Google Scholar
• Semkova I, Schilling M, Henrich-Noack P, et al. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res. 1996;717:44–54. doi:10.1016/0006-8993(95)01567-1
   PubMed Web of Science ®Google Scholar
• Zhu Y, Culmsee C, Semkova I, et al. Stimulation of β 2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia. J Cereb Blood Flow Metab. 1998;18(9):1032–1039. doi:10.1097/00004647-199809000-00013
   PubMed Web of Science ®Google Scholar
• Newman-Tancredi A, Verrièle L, Chaput C, et al. Down-regulation of rat beta-adrenoceptors by clenbuterol or desipramine does not require chronic treatment: [3H] CGP-12177 binding reveals rapid (24 hour) modulation. Brain Res Bull. 1996;41(2):93–96.
   PubMed Web of Science ®Google Scholar
• Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796–808. doi:10.1038/nm.2399
   PubMed Web of Science ®Google Scholar
• Liesz A, Rüger H, Purrucker J, et al. Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases. PLoS One. 2013;8(9):e74839. doi:10.1371/journal.pone.0074839
   PubMed Web of Science ®Google Scholar
• Liesz A, Hagmann S, Zschoche C, et al. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke. 2009;40(8):2849–2858. doi:10.1161/STROKEAHA.109.549618
   PubMed Web of Science ®Google Scholar
• Seifert HA, Hall AA, Chapman CB, et al. A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation. J Neuroimmune Pharmacol. 2012;7(4):1017–1024. doi:10.1007/s11481-012-9406-8
   PubMed Web of Science ®Google Scholar
• Gillespie JS, Hamilton DN. Binding of noradrenaline to smooth muscle cells in the spleen. Nature. 1966;212(5061):524–525. doi:10.1038/212524a0
   PubMed Web of Science ®Google Scholar
• Aboud R, Shafii M, Docherty JR. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br J Pharmacol. 1993;109(1):80–87. doi:10.1111/j.1476-5381.1993.tb13534.x
   PubMed Web of Science ®Google Scholar
• Ajmo CT, Collier LA, Leonardo CC, et al. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol. 2009;218:47–55. doi:10.1016/j.expneurol.2009.03.044
   PubMed Web of Science ®Google Scholar
• Felten DL, Felten SY, Carlson SL, et al. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol. 1985;135(2 Suppl):755s–765s.
   PubMed Web of Science ®Google Scholar
• Yan FL, Zhang JH. Role of the sympathetic nervous system and spleen in experimental stroke-induced immunodepression. Med Sci Monit. 2014;20:2489–2496. doi:10.12659/MSM.890844
   PubMed Web of Science ®Google Scholar
• Wang H, Deng QW, Peng AN, et al. β-arrestin2 functions as a key regulator in the sympathetic-triggered immunodepression after stroke. J Neuroinflammation. 2018;15(1):102. doi:10.1186/s12974-018-1142-4
   PubMed Web of Science ®Google Scholar
• Wardrop CA, Dagg JH, Lee FD, et al. Immunological abnormalities in splenic atrophy. Lancet. 1975;2(7923):4–7. doi:10.1016/S0140-6736(75)92949-9
   PubMed Web of Science ®Google Scholar
• Offner H, Subramanian S, Parker SM, et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol. 2006;176(11):6523–6531. doi:10.4049/jimmunol.176.11.6523
   PubMed Web of Science ®Google Scholar
• Haeusler KG, Schmidt WUH, Föhring F, et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis. 2008;25(1–2):50–58. doi:10.1159/000111499
   PubMed Web of Science ®Google Scholar
• Chen Y, Bodhankar S, Murphy SJ, et al. Intrastriatal B-cell administration limits infarct size after stroke in B-cell deficient mice. Metab Brain Dis. 2012;27(4):487–493. doi:10.1007/s11011-012-9317-7
   PubMed Web of Science ®Google Scholar
• Ren X, Akiyoshi K, Dziennis S, et al. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci. 2011;31(23):8556–8563. doi:10.1523/JNEUROSCI.1623-11.2011
   PubMed Web of Science ®Google Scholar
• Tarr AJ, Powel D, Reader BF, et al. β-adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption. Brain Behav Immun. 2012;26(8):1226–1238. doi:10.1016/j.bbi.2012.07.002
   PubMed Web of Science ®Google Scholar
• Diaz-Salazar C, Bou-Puerto R, Mujal AM, et al. Cell-intrinsic adrenergic signaling controls the adaptive NK cell response to viral infection. J Exp Med. 2020;217(4):e20190549. doi:10.1084/jem.20190549
   PubMed Web of Science ®Google Scholar
• Liu Q, Jin WN, Liu Y, et al. Brain ischemia suppresses immunity in the periphery and brain via different neurogenic innervations. Immunity. 2017;46(3):474–487. doi:10.1016/j.immuni.2017.02.015
   PubMed Web of Science ®Google Scholar
• Gan Y, Liu Q, Wu W, et al. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci U S A. 2014;111(7):2704–2709. doi:10.1073/pnas.1315943111
   PubMed Web of Science ®Google Scholar
• Zhang Y, Gao Z, Wang D, et al. Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10. J Neuroinflammation. 2014;11:79. doi:10.1186/1742-2094-11-79
   PubMed Web of Science ®Google Scholar
• Perry L, Love CP. Screening for dysphagia and aspiration in acute stroke: a systematic review. Dysphagia. 2001;16(1):7–18. doi:10.1007/PL00021290
   PubMed Web of Science ®Google Scholar
• Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344(9):665–671. doi:10.1056/NEJM200103013440908
   PubMed Web of Science ®Google Scholar
• Phan TG, Kooblal T, Matley C, et al. Stroke severity versus dysphagia screen as driver for post-stroke pneumonia. Front Neurol. 2019;10:16. doi:10.3389/fneur.2019.00016
   PubMed Web of Science ®Google Scholar
• Nous A, Peeters I, Nieboer K, et al. Post-stroke infections associated with spleen volume reduction: a pilot study. PLoS One. 2020;15(5):e0232497. doi:10.1371/journal.pone.0232497
   PubMed Web of Science ®Google Scholar
• Harms H, Reimnitz P, Bohner G, et al. Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis. 2011;32(6):552–560. doi:10.1159/000331922
   PubMed Web of Science ®Google Scholar
• O’Neill E, Yssel JD, McNamara C, et al. Pharmacological targeting of β 2-adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson’s disease. Br J Pharmacol. 2020;177(2):282–297. doi:10.1111/bph.14862
   PubMed Web of Science ®Google Scholar
• Izeboud CA, Hoebe KHN, Grootendorst AF, et al. Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation. Inflamm Res. 2004;53(3):93–99. doi:10.1007/s00011-003-1228-y
   PubMed Web of Science ®Google Scholar
• Nakamura A, Johns EJ, Imaizumi A, et al. Beta (2)-adrenoceptor agonist suppresses renal tumour necrosis factor and enhances interleukin-6 gene expression induced by endotoxin. Nephrol Dial Transplant. 2000;15(12):1928–1934. doi:10.1093/ndt/15.12.1928
   PubMed Web of Science ®Google Scholar